and action of both the cells and the soluble factors of the immune system. Protein, antioxidants, essential fatty acids, and certain vitamins, and minerals are all keys to a healthy immune system. Also moderate exercise helps to quickly circulate white blood cells, part of the immune system's response to foreign bacteria, allowing a quick response to illness 4 . Nursing care of patients receiving chemotherapy begins with physical and psychological preparation. The oncology nurse must review the treatment plan with oncologist to be aware of expected outcomes and possible complications, and assess the patient's general physical and emotional status 5 .The aim of the current study is to determine the effect of immune enhancement on clinical outcomes of mastectomy patients undergoing chemotherapy.
SuBjEctS And MEtHod
A case control hospital based study was conducted at oncology department, Menofia University Hospital. Data were collected from February to December 2011 over a period of 11 months.A sample of 60 adult female patients with early stage breast cancer were selected and randomly assigned by simple random sample matched cases with control (two equal groups of 30 patients: Study (Group I): received health teaching about management of chemotherapy side effects and immune enhancement through (diet, exercise, and lifestyle modification), while control (Group II): exposed to routine hospital care).
Inclusion criteria:
• written consent • Age from 30-60 years old newly admitted to chemotherapy.
• white blood cells and red blood cells within normal value.
• No other associated diseases as diabetes mellitus.
• Patients received adjuvant chemotherapy in the form of FAC (Fluorouracil-DoxorubicinCyclophosphamide) regimen repeated every 21 days for 6 cycles. 
Statistical analysis:
Data entry and statistical analysis were done using SPSS version 11.
• Qualitative categorical variables were compared using chi-square test.
• T-test and Mann-whitney test were used to determine the level of significance between the quantitative variables for both groups.
• Paired t-test was used for comparison of changes in mean values of two situations for the same group.
• P-Value of 0.05 or less was used to assess the significance of results (Mann, 2004) .
rESultS
The mean age in both groups was about 42 and 41 and mostly both were from rural areas. All patients characteristics are seen in Table (1) . There was an improvement of a mean total knowledge score among study group (2.60 ± 2.19) at pre intervention to become 5.97 ± 3.09 after 1st cycle of chemotherapy, 6.80 ± 3.41 after 3rd cycle of chemotherapy, and 8.27 ± 3.41 after 6th cycle of chemotherapy) than control group at post intervention. Table ( 2) shows the effect of teaching on patient's knowledge related to immune system.A statistical significant differences existed in performance status for usual activities between both groups after 1st cycle of chemotherapy, after 3rd cycle of chemotherapy and after the 6th cycle of chemotherapy post intervention in relation to performance status for usual activities as (P-value <0.05).Post intervention fatigue in Table ( 3) showed statistically significant improvement between study and control groups after 3rd and 6th cycle of chemotherapy(P-value: <0.01). As seen in Table (4) there were statistically significant differences existed between study and control groups regarding number of meals taken per day, taking regular meals, type of meat, chicken, vegetables, and methods of cooking food after 3rd and 6th cycles of chemotherapy.
And there was statistically significant differences existed regarding eating fruits (P-value: <0.05), and buying food (P-value: <0.01) post intervention (after 3rd and 6th cycles of chemotherapy).After chemotherapy there was a statistical significant improvement (P-value: <0.05) in mean value of hemoglobin (12.0 ± 0.5), hematocrit (37.04 ± 1.8), wBCs (5.0 ± 0.46) and albumin (4.1 ± 0.21) for study group. There was a statistically significant (P-value: <0.05) decrease in the mean value of (CD90 (+ve) CD45 (+ve) %) (8.37 ± 2.45) in the study group than (11.24 ± 2.99) of the control group.The effect on (QOL)is shown in Table (5) . <0.01** < 0.01** < 0.01** < 0.01** <0.05* *Statistically significant at P < 0.05, **Highly Statistical significant at P < 0.01
dIScuSSIon
The problem of dealing with cancer patients becomes more complex especially when those patients are not well educated and do not know enough data about their disease and its management. This problem is significantly high in developing countries. In Menofia governorate we face this problem even in more difficulty as a lot of our patients are illiterate. Up to our knowledge there was no study addressing these issues in breast cancer patients. The knowledge of the present sample at pre intervention revealed that there were no statistically significant differences existed among patients of both groups related to breast cancer, chemotherapy side effects & its management, and immune system. Coughlane 6 stated that patients receiving chemotherapy displayed a poor knowledge of the potential side-effects of their chemotherapy and the names of the drugs they were receiving as part of their treatment. The patient's knowledge about chemotherapy side effects and immune system enhancement improved in study group after educations which was supported by Keller 7 who said that an educational intervention provided by nurses before the start of chemotherapy may assist women with breast cancer to increase their knowledge of chemotherapy treatment, enhance their ability to manage side effects, and improve their coping strategies. An improvement was noticed in the total score of fatigue, performance status, and quality of life among patients in study group over time may be attributed to patient response to intervention that include health teaching about management of chemotherapy side effects, and immune enhancement through (diet, exercise, and life style modification). Nail8 stated that untreated cancer fatigue may result in a decrease or discontinuation of normal physical, social, interpersonal, and recreational activities. Patients may also experience difficulty adhering to and completing treatment regimens and may require delays in treatment, dose limitation, or discontinuation of therapy or may withdraw from clinical trials because of fatigue .Also Brolinson&Elliott 9 mentioned that the immune system of people who exercise regularly is stronger than of those who do not. Our study showed that there was statistically significant difference between study and control groups regarding items related to nutritional assessment at different sessions and laboratory results for hemoglobin, hematocrit, albumin, and CD90 (+ve) CD45 (+ve) %. This might be explained by effective management of chemotherapy side effects such as nausea, and vomiting that has effect on food intake and health teaching about diet, exercise and life style modification that enhance immune system through natural killer (NK) cells and other components of immune system that directly involved in killing cancer cells. This is supported by wagner and Bornstein 10 who advised that nutritional assessment should occur at the time of diagnosis, and continue throughout the course of treatment. Also Eldridge 11 stated that side effects of chemotherapy, as well as the cancer itself, can greatly affect nutritional status, healthcare providers need to anticipate possible problems and educate the patient about them in an effort to prevent malnutrition and weight loss which can affect a patient's ability to regain health and acceptable blood counts between chemotherapy cycles. Finally Cadmus, and Salovey
12
, mentioned that the rehabilitation programs for cancer patients involve a combination of physical and psychological interventions that improve the patient's physical comfort and ability to function. we concluded that management of chemotherapy side effects and Immune enhancement has a positive effect on reduction of chemotherapy side effects and fatigue of the study group than control group.So we recommend providing counseling for patients receiving chemotherapy to help them overcome and manage the side effects of chemotherapy. Further research is needed with large sample size for generalization of the results as well as evaluating the clinical benefit (in term of response rate and survival) of breast cancer patients.
rEFErEncES

